Literature DB >> 12011055

A novel p53 transcriptional repressor element (p53TRE) and the asymmetrical contribution of two p53 binding sites modulate the response of the placental transforming growth factor-beta promoter to p53.

Jeffrey Wong1, Pei-Xiang Li, Henry J Klamut.   

Abstract

Previous studies in our laboratory and others identified placental transforming growth factor-beta (PTGF-beta) as an important downstream mediator of DNA damage signaling and a transcriptional target of p53. Here we show that accumulation of PTGF-beta mRNA in response to p53 overexpression is delayed relative to p21(WAF1), whereas the promoters of these genes respond to p53 with similar kinetics. Mutational analyses of two p53 binding sites within the PTGF-beta promoter revealed that site p53-1 (+29 bp) is responsible for as much as 80% of the transcriptional response to p53. This is consistent with electrophoretic mobility shift assays showing that site p53-1 binds p53 with a much higher affinity than site p53-2 (-850 bp). We also describe for the first time a novel 21-bp element (-222 to -242 bp) that acts to down-regulate the PTGF-beta promoter response to p53. Termed the p53 transcriptional repressor element (p53TRE), this sequence was shown to suppress p53 transactivation in a position- and promoter-independent fashion and to associate with a 28-kDa protein expressed in several tumor cell lines. A p53 suppressor element and asymmetric p53 binding sites may participate determining the activation thresholds of p53-responsive promoters in a cell- and context-specific manner.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12011055     DOI: 10.1074/jbc.M203020200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Macrophage inhibitory cytokine-1 regulates melanoma vascular development.

Authors:  Sung Jin Huh; Chin-Ying Chung; Arati Sharma; Gavin P Robertson
Journal:  Am J Pathol       Date:  2010-04-29       Impact factor: 4.307

2.  Divergent evolution of human p53 binding sites: cell cycle versus apoptosis.

Authors:  Monica M Horvath; Xuting Wang; Michael A Resnick; Douglas A Bell
Journal:  PLoS Genet       Date:  2007-06-15       Impact factor: 5.917

3.  The transcription factor p53: not a repressor, solely an activator.

Authors:  Martin Fischer; Lydia Steiner; Kurt Engeland
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 4.  PDRG1 at the interface between intermediary metabolism and oncogenesis.

Authors:  María Ángeles Pajares
Journal:  World J Biol Chem       Date:  2017-11-26

5.  FOXP1 and NDRG1 act differentially as downstream effectors of RAD9-mediated prostate cancer cell functions.

Authors:  Sunil K Panigrahi; Constantinos G Broustas; Ping Q Cuiper; Renu K Virk; Howard B Lieberman
Journal:  Cell Signal       Date:  2021-07-21       Impact factor: 4.850

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.